Pharmaceutical Benefits Scheme (PBS) prescription—bioequivalent allowed indicator, code A
Data Element Attributes
Identifying and definitional attributes | |
Metadata item type: | Data Element |
|---|---|
| Short name: | Bioequivalent allowed indicator |
| Synonymous names: | Bioequivalent indicator; Brand equivalent allowed indicator |
| METEOR identifier: | 605962 |
| Registration status: | Commonwealth Department of Health, Retired 19/10/2023 |
| Definition: | An indicator of whether a bioequivalent brand of a medicinal product is allowed to be substituted for the brand prescribed from the Schedule of Pharmaceutical Benefits, as represented by a code. |
| Data Element Concept: | Pharmaceutical Benefits Scheme (PBS) prescription—bioequivalent allowed indicator |
| Value Domain: | Bioequivalent allowed indicator code A |
Value domain attributes | ||
Representational attributes | ||
| Representation class: | Code | |
|---|---|---|
| Data type: | String | |
| Format: | A | |
| Maximum character length: | 1 | |
| Value | Meaning | |
| Permissible values: | a | Able to be substituted with other 'a flagged' brands |
| b | Able to be substituted with other 'b flagged' brands | |
| Supplementary values: | blank | Not able to be substituted with other brands |
Collection and usage attributes | |
| Guide for use: | The permissible values for this value domain should be reported in lowercase only. CODE a Able to be substituted with other 'a flagged' brands This code is used to identify those medicinal products for which either:
CODE b Able to be substituted with other 'b flagged' brands This code is used to identify those brands of medicinal products that are considered to be bioequivalent or therapeutically equivalent, but for which it is not known if there is equivalence between brands marked 'a' and those marked 'b'. More information about brand equivalence is available from the relevant section of the 'Symbols used in the Schedule' page of the Schedule of Pharmaceutical Benefits - see the Reference documents section below. |
|---|---|
Source and reference attributes | |
| Submitting organisation: | Department of Health |
|---|---|
| Reference documents: | Department of Health 2015. Schedule of Pharmaceutical Benefits. Department of Health, Canberra. Viewed 18 September 2015, |
Data element attributes | |
Collection and usage attributes | |
| Guide for use: | This data element is used to identify different brands of the same drug, form and strength that can be substituted by the pharmacist. The underlying assumption is that the brand has been declared as bioequivalent by the Therapeutic Goods Administration (TGA), following a request by the manufacturer. Within the Schedule of Pharmaceutical Benefits, bioequivalent medicinal products are flagged as being either 'Brand equivalent a' or 'Brand equivalent b'. 'Brand equivalent a' medicinal products are those for which either:
'Brand equivalent b' medicinal products are those brands that are considered to be bioequivalent or therapeutically equivalent, but for which it is not known if there is equivalence between brands marked 'a' and those marked 'b'. More information about brand equivalence is available from the relevant section of the 'Symbols used in the Schedule' page of the Schedule of Pharmaceutical Benefits - see the Reference documents section below. |
|---|---|
Source and reference attributes | |
| Submitting organisation: | Department of Health |
| Reference documents: | Department of Health 2015. Schedule of Pharmaceutical Benefits. Department of Health, Canberra. Viewed 18 September 2015, |
Relational attributes | |
| Implementation in Data Set Specifications: | Pharmaceutical Benefits Scheme (PBS) state/territory data extract 2013-14 Commonwealth Department of Health, Retired 19/10/2023 |